Commercializing Successful Biomedical Technologies Basic Principles for the Development of Drugs, Diagnostics and Devices
Book contents
- Frontmatter
- Contents
- Foreword by F. L. Douglas
- Preface
- Acknowledgements
- 1 The biomedical drug, diagnostic, and devices industries and their markets
- 2 Markets of interest and market research steps
- 3 Intellectual property, licensing, and business models
- 4 New product development (NPD)
- 5 The regulated market: gateway through the FDA
- 6 Manufacturing
- 7 Reimbursement, marketing, sales, and product liability
- Glossary and acronyms
- Index
- References
4 - New product development (NPD)
Published online by Cambridge University Press: 05 September 2012
Book contents
- Frontmatter
- Contents
- Foreword by F. L. Douglas
- Preface
- Acknowledgements
- 1 The biomedical drug, diagnostic, and devices industries and their markets
- 2 Markets of interest and market research steps
- 3 Intellectual property, licensing, and business models
- 4 New product development (NPD)
- 5 The regulated market: gateway through the FDA
- 6 Manufacturing
- 7 Reimbursement, marketing, sales, and product liability
- Glossary and acronyms
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Commercializing Successful Biomedical TechnologiesBasic Principles for the Development of Drugs, Diagnostics and Devices, pp. 104 - 171Publisher: Cambridge University PressPrint publication year: 2008
References
Pollack, A. High court rethinks what can be patented, The New York Times, Monday, March 20, 2006.
, , , and Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Advanced Drug Delivery Reviews, 23, 3–25, 1997.CrossRefGoogle Scholar
, , , et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration, Clinical Chemistry, 49, 7–18, 2003.CrossRefGoogle ScholarPubMed
and Corporate Venturing: Creating New Businesses within the Firm, Harvard Business School Press, 1993.Google Scholar
The Innovator's Dilemma: The Revolutionary Book that Will Change the Way You Do Business, Harvard Business School Press, Reprint 2003.Google Scholar
The new product process: a decision guide for managers. Journal of Marketing Management, 3, (3) 238–255, 1988.CrossRefGoogle Scholar
, , and The price of innovation: new estimates of drug development costs, Journal of Health Economics, 22, 151–185, 2003.CrossRefGoogle Scholar
, Matrix organization designs – how to combine functional and project forms, Business Horizons, 17, 1, 29–40, 1971.CrossRefGoogle Scholar
and Organizing for product development projects, Journal of Product Innovation Management, 5, 180–190, 1988.CrossRefGoogle Scholar
, , , et al. Radical Innovation: How Mature Companies can Outsmart Upstarts, Harvard Business School Press, 2000.Google Scholar
, , and Marketing and discontinuous innovation: the probe and learn process, California Management Review, 38(3), 8–37, 1996.CrossRefGoogle Scholar
Biomedical and Clinical Instrumentation: Fast Tracking from Concept through Production in a Regulated Environment. Interpharm Press, 1994.Google Scholar
The Development Factory: Unlocking the Potential of Process Innovation, Harvard Business School Press, 1996.Google Scholar
, , and Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964–1985), British Journal of Clinical Pharmacology, 25, 387–396, 1988.CrossRefGoogle Scholar
Project Management Institute, A Guide to the Project Management Body of Knowledge (PMBOK®), Project Management Institute, 3rd edn., 2004.
Creating Technology Strategies: How to Build Competitive Biomedical R&D, Wiley-Liss, 1997.Google Scholar
Development of FDA-Regulated Medical Products: Prescription Drugs, Biologics, and Medical Devices, ASQ Quality Press, 2nd edn., 2003.Google Scholar